Bracken M B
Perinatal Epidemiology Unit, Yale University Medical School, New Haven, Conn.
Fetal Ther. 1987;2(1):2-6. doi: 10.1159/000263272.
Randomized clinical trials have not provided unequivocal justification for the routine use of ultrasound in antenatal management. Nonetheless, routine ultrasonography is widely practiced in many places, there is no evidence to suggest it is biologically harmful, and its diagnostic capabilities are being increasingly documented. There are, however, no studies of the clinical, psychological or economic benefits of routine ultrasound in clinically low-risk patients who would not normally be scanned. To avoid continuing uncertainty about the risks and benefits of routine ultrasound, randomized trials should be conducted of future developments in technique and procedure in places where routine scanning is common. In places which have not adopted routine scanning randomized trials could still answer fundamental questions about routine use of the technique.
随机临床试验并未为超声在产前管理中的常规使用提供明确的依据。尽管如此,常规超声检查在许多地方仍被广泛应用,没有证据表明其具有生物危害性,而且其诊断能力也越来越多地得到记录。然而,对于临床上通常不会接受扫描的低风险患者,尚未有关于常规超声检查的临床、心理或经济效益的研究。为避免对常规超声检查的风险和益处持续存在不确定性,应在常规扫描普遍的地方对技术和程序的未来发展进行随机试验。在尚未采用常规扫描的地方,随机试验仍可回答有关该技术常规使用的基本问题。